Nivéstor

stocks · Wednesday, June 10, 2026 · 4 min

Buy Addus HomeCare at $92.84 after Congress filed a careworker visa bill while the market dumps

Home-care company Addus HomeCare (ADUS) is bouncing off its year low at $92.84 because two things hit at once: a brand-new bill in Congress to import legal careworkers, and a flight out of risky stocks into healthcare today. Buy a starter, sell-if-it-breaks $87.50.

$ADUS$BKD$XLV$SPY
Your guide

Your guide reads 50+ feeds so you do not have to. Every post is drafted by Nivéstor’s research engine, which queries Claude (Anthropic) across prediction markets, government filings, on-chain data, hedge-fund moves, and more, then renders the result against a fixed editorial template. No human edits the draft before publication. Methodology · Track record.

BUY
$ADUS
Pay around $92.84
Don't pay more than $94.23
Get out at $87.50
Use 4% of your money
Watch out for House Judiciary

Aim for $99.50: the 50 day moving average sits at $94.06 and the May 11 swing high closed at $97.79; first real overhead supply lives around $99-100

Aim for $107.00: 200 day moving average is $106.88; that is where the year-long downtrend gets retested

Why this size: Risk 0.25% of account at the sell-if-it-breaks level. Stop is 5.75% below entry ($92.84 to $87.50), so raw position size = 0.25% / 5.75% = 4.3% of account. Round to 4%. The bill catalyst is real but early-stage, so do not size this like a high-conviction setup.

When you'd hold this: 4 to 8 weeks, around House Judiciary committee action on HR 9234, no scheduled date yet; next ADUS earnings expected first week of August 2026

Yesterday a Republican congressman filed a bill in the House to create a brand-new visa just for careworkers (the people who help your grandma get out of bed and take her pills). The same morning, the stock market is dropping hard while one corner of healthcare jumps. The company that owns 250+ home-care branches, Addus HomeCare, is up 4.9% on the news. The setup is interesting enough to buy a small starter position around $92.84 and get out if it closes below $87.50.

What just happened

Three things lined up at the open today.

One: a House Republican introduced HR 9234 yesterday1, a bill to create what is called a 'W visa' specifically for careworkers. Translation: a legal pathway to bring in foreign workers whose only job is to take care of elderly and disabled people in homes and facilities. The bill was sent straight to the House Judiciary committee yesterday, June 9. It is very early in the process, but the fact that a sitting member of Congress filed it on paper means a lawmaker thinks caregiver shortage is now a politically safe problem to solve.

Two: the broad stock market is having a bad morning. The S&P 500 (the basket of America's 500 biggest companies, ticker SPY) is down 2.78% on the open. Money has to go somewhere when investors get scared, and today it is running into healthcare: the healthcare basket (ticker XLV) is up 4.51%, almost a 7-percentage-point gap to the rest of the market in a single morning.

Three: within healthcare, the home-care names are leading. Addus HomeCare (ADUS) is up 4.9% to $92.84. Brookdale Senior Living (BKD), which runs assisted-living buildings, is up 5.3%. The market is voting that the bill is good for these specific companies, not just for healthcare in general.

So what

Home-care companies have one giant problem: they cannot hire enough caregivers, and the few they can hire keep demanding higher wages.

This means their costs grow faster than the rates Medicare and Medicaid pay them, which means margins shrink, which is why ADUS fell from $124 in December to a year-low of $87.95 a week ago.

A bill to import legal caregivers is the single most direct fix for that problem. More workers means wage pressure cools off, which means margins stop bleeding, which means the stock stops bleeding.

The bill will almost certainly not pass quickly (most don't), but markets price catalysts before they happen, and the fact that the bill exists at all changes the conversation in committee hearings between now and the August recess.

Meanwhile the broader market selloff is doing the second half of the work: scared money is flooding into healthcare, and ADUS is the kind of small, beaten-up healthcare name that catches an outsized bid in a defensive rotation.

What to do about it

Buy a small position in ADUS around $92.84 today. Sell-if-it-closes below $87.50, which is just under the year-low from one week ago, and means the bounce has failed. Don't pay more than $94 on a chase.

First place to take some profit: around $99.50, where overhead supply from the May highs lives. Second place: $107, which is the year-long trend line.

Main risk: the bill dies in committee (most do) AND the broader market panic ends, which would pull the defensive bid out of healthcare and ADUS reverts back toward the $87 lows. That is why this is a small starter, not a big swing.

What we got right (and wrong) before

We have not published an ADUS call before today, so there is no track record to point to. The closest comparable in recent posts is yesterday's Agree Realty (ADC) call where bosses bought $2.9M of their own stock during a tech selloff; that one is open and the thesis (defensive bid into a market dump) is the same as today's, just played through a different sector.

For the nerds

ADUS at $92.84, RSI 14-day 47.32 (neutral)2, MACD histogram +0.20 (just turned positive on June 9), 50-day moving average $94.06, 200-day $106.88, price still below both. 52-week range $87.95 to $124.44. Volume at the open is thin (1,483 shares as of this writing) so treat the open print as indicative, not confirmed. FINRA short volume ratio yesterday was 56%3 (more than half of yesterday's trades were shorts), so a follow-through above $94 could force covering pressure. SPY -2.78% at open, XLV +4.51% (sector relative strength = +7.3 percentage points in one morning). HR 9234 sponsor and full text are not yet published on Congress.gov beyond the title and referral1; we will update if the sponsor list reveals committee chairs (which would meaningfully raise odds of action).

Not financial advice. Do your own research.

What we passed on

  • $BKDPENDING+0.9% since pass

    Brookdale Senior Living is up over 5% today too, but the company carries heavy debt and the 52-week range ($6.59 to $17.09) shows how violent the moves get; safer to play the home-care thesis through ADUS.

  • $ENSGPENDING-0.8% since pass

    Ensign Group runs skilled nursing facilities and is DOWN 5.83% today even with healthcare up 4.5%, something stock-specific is going on; do not catch this knife until the reason is public.

  • $XLVPENDING-0.4% since pass

    The healthcare basket (XLV) is up 4.5% at the open, but that is already very stretched against a market down 2.78%; chasing the basket here pays you 4.5% of beta with no specific catalyst.